[Significance of superior vena cava reconstruction with EPTFE grafts in the surgical treatment of superior and anterior mediastinal invasive malignant tumors]
- PMID: 2214404
[Significance of superior vena cava reconstruction with EPTFE grafts in the surgical treatment of superior and anterior mediastinal invasive malignant tumors]
Abstract
The objective of this study is to demonstrate the significance of superior vena cava (SVC) reconstruction in the surgical treatment of superior and anterior mediastinal invasive malignant tumors, by using a total of 48 cases consisting of 36 invasive thymomas, 3 thymic cancers, 3 carcinoids, 2 germ cell tumors, 2 malignant lymphomas, 1 intrathoracic thyroid cancer and 1 malignant melanoma. In 22 of 48 cases there was only mediastinal pleural invasion or tumor capsule invasion, on the other hand, 26 cases had high ratios of invasion to adjacent organs, including lung, pericardium, great veins and the phrenic nerve. Sixteen of 26 cases had invasion to 1-2 adjacent organs, but 10 had 3-6 organ invasion. Among 12 cases invading SVC or brachiocephalic veins, 9 cases during the last 7 years underwent SVC resection and reconstruction with EPTFE grafts. The patency was good in the grafts with external ring support and no SVC symptoms were observed in all cases postoperatively. The longest patent and functional graft is 40 months postoperative. No statistically significant difference were demonstrated in the survivals between cases with SVC reconstruction and those with resections of other adjacent organs, furthermore, remarkable difference of survival was demonstrated in SVC reconstructed cases with complete resection and incomplete resection. The survivals in cases with combined resection of 1-2 adjacent organs was statistically significantly better than those with combined resection of 3-6 adjacent organs (p less than 0.05, Cox-Mantel test).(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Long-term follow-up after prosthetic replacement of the superior vena cava combined with resection of mediastinal-pulmonary malignant tumors.J Thorac Cardiovasc Surg. 1991 Aug;102(2):259-65. J Thorac Cardiovasc Surg. 1991. PMID: 1865699
-
Long-term graft patency after replacement of the brachiocephalic veins combined with resection of mediastinal tumors.J Thorac Cardiovasc Surg. 2005 Apr;129(4):809-12. doi: 10.1016/j.jtcvs.2004.05.001. J Thorac Cardiovasc Surg. 2005. PMID: 15821647
-
Prosthetic reconstruction of the superior vena cava for malignant disease: surgical techniques and outcomes.Ann Thorac Surg. 2010 Jul;90(1):223-8. doi: 10.1016/j.athoracsur.2010.03.050. Ann Thorac Surg. 2010. PMID: 20609780
-
[Mediastinal malignant tumor resection and superior vena cava revascularization. Resection of invasive thymoma with growth into the superior vena cava and right atrium using cardiopulmonary bypass].Nihon Kyobu Geka Gakkai Zasshi. 1995 May;43(5):717-9. Nihon Kyobu Geka Gakkai Zasshi. 1995. PMID: 7561298 Review. Japanese. No abstract available.
-
[Surgical vein reconstruction in patients with tumor invasiveness of the superior caval system. Retrospective study of 7 cases].J Chir (Paris). 1996 Apr;133(2):61-4. J Chir (Paris). 1996. PMID: 8763562 Review. French.
Cited by
-
Superior Vena Cava Resection in Locally Advanced Thymoma-Surgical and Survival Outcomes.Indian J Surg Oncol. 2020 Dec;11(4):711-719. doi: 10.1007/s13193-020-01204-5. Epub 2020 Sep 4. Indian J Surg Oncol. 2020. PMID: 33299285 Free PMC article.
-
[Use of autologous femoral vein in superior vena cava thrombosis. Case report and review of the literature].Langenbecks Arch Chir. 1994;379(2):120-2. doi: 10.1007/BF00195874. Langenbecks Arch Chir. 1994. PMID: 8196427 Review. German.